The FDA has not approved these alternative delivery methods, and theres no guarantee theyll be absorbed properly or provide the intended therapeutic effects
Thus, inhibition of DPP-IV has been suggested as a feasible alternative to elevate circulating GLP-1 levels, and circumvent the limitations of GLP-1 administration [323][324][325][326][327][328][329][330]
387 2 2.5mg1INJE800021,10011 3 3mg6RYBE350028,02755011 1 30 1 GLP-1 1 2 BMI BMI18.5GLP-1 BMI GLP-1 GLP-1 GLP-1 GLP-1 GLP-1GLP-1 1 GIP GLP-1 GLP-1GIPGIP/GLP-1 GIPGLP-1 1 GLP-1 1 21 GLP-11 120ml 302 30 GLP-1 3mg7mg14mg 3mg7mg14mg3 3mg 13mg7mg 1 1 GLP-1 1012 1GLP-1GIP 28 3021 308 1 : 1 : 3 -6kg : 1/4 119,115 11 : 11 : : 14,527 1 170cmBMI27 : Tirzepatide Once Weekly for the Treatment of Obesity
Regarding FDA approvals , Mounjaro is primarily approved for managing type 2 diabetes , although it has shown significant weight loss in studies
Both approaches work, as long as storage protocols are followed
Good sleep and self-care help control hunger and boost energy for activity
